Luminex Gets FDA OK for Swine Flu Data in xTAG Panel | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex today said that the US Food and Drug Administration has cleared labeling updates for its xTAG Respiratory Viral Panel to include data about the performance of the test in humans infected with the pandemic A/H1N1 influenza virus, also known as swine flu.

The labeling will now include information from two studies that Luminex said shows that xTAG RVP can be an effective aid in detecting the virus, but cannot identify the hemagglutinin gene of the 2009 influenza A/H1N1 in clinical specimens.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.